SAMRAT PHARMACHEM Financial Statement Analysis
|
||
|
The Revenues of SAMRAT PHARMACHEM have increased by 40.09% YoY .
The Earnings Per Share (EPS) of SAMRAT PHARMACHEM has decreased by -3.22 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SAMRAT PHARMACHEM Last 5 Annual Financial Results
[BOM: 530125]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹311 Cr | ₹222 Cr | ₹179 Cr | ₹137 Cr | ₹111 Cr |
| Expenses | ₹287 Cr | ₹198 Cr | ₹170 Cr | ₹131 Cr | ₹108 Cr |
| Operating Profit (Excl OI) | ₹24 Cr | ₹24 Cr | ₹8.67 Cr | ₹6.63 Cr | ₹3.18 Cr |
| Other Income | ₹0.48 Cr | ₹0.63 Cr | ₹0.46 Cr | ₹0.57 Cr | ₹0.46 Cr |
| Interest | ₹1.23 Cr | ₹0.68 Cr | ₹1.28 Cr | ₹0.98 Cr | ₹1.06 Cr |
| Depreciation | ₹0.64 Cr | ₹0.60 Cr | ₹0.49 Cr | ₹0.43 Cr | ₹0.42 Cr |
| Profit Before Tax | ₹23 Cr | ₹24 Cr | ₹7.34 Cr | ₹5.79 Cr | ₹2.16 Cr |
| Profit After Tax | ₹17 Cr | ₹17 Cr | ₹5.33 Cr | ₹4.24 Cr | ₹1.54 Cr |
| Consolidated Net Profit | ₹17 Cr | ₹17 Cr | ₹5.33 Cr | ₹4.24 Cr | ₹1.54 Cr |
| Earnings Per Share (Rs) | ₹53.83 | ₹55.62 | ₹17.26 | ₹13.71 | ₹4.97 |
| PAT Margin (%) | 5.35 | 7.75 | 2.61 | 2.70 | 1.22 |
| ROE(%) | 30.25 | 44.95 | 19.77 | 19.10 | 7.96 |
| ROCE(%) | 34.91 | 52.33 | 23.90 | 22.43 | 11.80 |
| Total Debt/Equity(x) | 0.30 | 0.16 | 0.30 | 0.39 | 0.33 |
Key Financials |
||
| Market Cap | : | ₹ 113.2 Cr |
| Revenue (TTM) | : | ₹ 268.1 Cr |
| Net Profit(TTM) | : | ₹ 0.0 Cr |
| EPS (TTM) | : | ₹ 0.1 |
| P/E (TTM) | : | 5,144.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SAMRAT PHARMACHEM | 1% | -9% | -10.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
SAMRAT PHARMACHEM Revenues
[BOM: 530125]
| Y-o-Y | 40.09 % |
| 5 Yr CAGR | 29.30 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹311 Cr | 40.09 | |
| Mar2022 | ₹222 Cr | 23.87 | |
| Mar2021 | ₹179 Cr | 30.24 | |
| Mar2020 | ₹137 Cr | 23.68 | |
| Mar2019 | ₹111 Cr | - | |
SAMRAT PHARMACHEM Operating Profit
[BOM: 530125]
| Y-o-Y | -1.28 % |
| 5 Yr CAGR | 65.66 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹24 Cr | -1.28 | |
| Mar2022 | ₹24 Cr | 179.61 | |
| Mar2021 | ₹8.67 Cr | 30.76 | |
| Mar2020 | ₹6.63 Cr | 108.66 | |
| Mar2019 | ₹3.18 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -29.55 % |
| 5 Yr CAGR | 28.09 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 7.7% | -29.55 | |
| Mar2022 | 10.93% | 125.83 | |
| Mar2021 | 4.84% | 0.41 | |
| Mar2020 | 4.82% | 68.53 | |
| Mar2019 | 2.86% | - | |
SAMRAT PHARMACHEM Profit After Tax
[BOM: 530125]
| Y-o-Y | -3.22 % |
| 5 Yr CAGR | 81.40 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹17 Cr | -3.22 | |
| Mar2022 | ₹17 Cr | 222.24 | |
| Mar2021 | ₹5.33 Cr | 25.87 | |
| Mar2020 | ₹4.24 Cr | 175.85 | |
| Mar2019 | ₹1.54 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -30.97 % |
| 5 Yr CAGR | 44.71 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 5.35 % | -30.97 | |
| Mar2022 | 7.75 % | 196.93 | |
| Mar2021 | 2.61 % | -3.33 | |
| Mar2020 | 2.7 % | 121.31 | |
| Mar2019 | 1.22 % | - | |
SAMRAT PHARMACHEM Earnings Per Share (EPS)
[BOM: 530125]
| Y-o-Y | -3.22 % |
| 5 Yr CAGR | 81.41 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹54 | -3.22 | |
| Mar2022 | ₹56 | 222.25 | |
| Mar2021 | ₹17 | 25.89 | |
| Mar2020 | ₹14 | 175.86 | |
| Mar2019 | ₹4.97 | - | |
SAMRAT PHARMACHEM Return on Capital Employed (ROCE)
[BOM: 530125]
| Y-o-Y | -33.29 % |
| 5 Yr CAGR | 31.15 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 34.91% | -33.29 | |
| Mar2022 | 52.33% | 118.95 | |
| Mar2021 | 23.9% | 6.55 | |
| Mar2020 | 22.43% | 90.08 | |
| Mar2019 | 11.8% | - | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Current Share Price | : | ₹365.1 |
| Current MarketCap | : | ₹ 113.2 Cr |
| Updated EOD on | : | Apr 18,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 1% |
-9% |
-10.4% |
| SENSEX | -2.9% |
-0.4% |
20% |
SAMRAT PHARMACHEM related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SAMRAT PHARMACHEM Financials
How the annual revenues of SAMRAT PHARMACHEM have changed ?
The Revenues of SAMRAT PHARMACHEM have increased by 40.09% YoY .
How the Earnings per Share (EPS) of SAMRAT PHARMACHEM have changed?
The Earnings Per Share (EPS) of SAMRAT PHARMACHEM has decreased by -3.22 % YoY .
Check out Intrinsic Value of Peers of SAMRAT PHARMACHEM
Compare Stock Analytics of Peers of SAMRAT PHARMACHEM
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
